CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas
Gespeichert in:
| Veröffentlicht in: | Journal of investigative dermatology 2023-07, Vol.143 (7), p.1329-1332.e3 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1332.e3 |
|---|---|
| container_issue | 7 |
| container_start_page | 1329 |
| container_title | Journal of investigative dermatology |
| container_volume | 143 |
| creator | Ta, Van Anh Battistella, Maxime Zhao, Lin Pierre Dobos, Gabor Ram-Wolff, Caroline Madelaine, Isabelle Bories, Jean-Christophe Tournilhac, Olivier Rouanet, Jacques Veyrat-Masson, Richard Bouaziz, Jean-David Marie-Cardine, Anne Bagot, Martine Bensussan, Armand Moins-Teisserenc, Hélène De Masson, Adèle |
| description | |
| doi_str_mv | 10.1016/j.jid.2023.01.009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04613153v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022202X23000271</els_id><sourcerecordid>2771334564</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3381-4b1aa21be74d597d4c9a8039cabb08c6472b7b66410086a2bd98770253d421383</originalsourceid><addsrcrecordid>eNp9kMGO0zAQhi0EYsvCA3BBOYK0CTO2YyfiVIWFXakICRWJm-U4066rJil2Wqlvj6sse9yTpfH3_5r5GHuPUCCg-rwrdr4rOHBRABYA9Qu2wJKLHLXUL9kCgPM8ff-5Ym9i3EHKyLJ6za6E0qhqzhfsR_NVVNnahi1NfthmfsiW222gGP2JbrJ1IDv1NEz5L9oE66YxnLPmONmBxmPM1nlD-322OveHh7G38S17tbH7SO8e32v2-9vturnLVz-_3zfLVe6EqDCXLVrLsSUtu7LWnXS1rUDUzrYtVE5JzVvdKiURoFKWt11daQ28FJ3kKCpxzT7NvQ92bw7B9zaczWi9uVuuzGUGUqHAUpwwsR9n9hDGv0eKk-l9dGnt-QbDtUYhZKlkQnFGXRhjDLR56kYwF-NmZ5JxczFuAE0ynjIfHuuPbU_dU-K_4gR8mQFKQk6egonO0-Co84HcZLrRP1P_D_Pgjeg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2771334564</pqid></control><display><type>article</type><title>CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ta, Van Anh ; Battistella, Maxime ; Zhao, Lin Pierre ; Dobos, Gabor ; Ram-Wolff, Caroline ; Madelaine, Isabelle ; Bories, Jean-Christophe ; Tournilhac, Olivier ; Rouanet, Jacques ; Veyrat-Masson, Richard ; Bouaziz, Jean-David ; Marie-Cardine, Anne ; Bagot, Martine ; Bensussan, Armand ; Moins-Teisserenc, Hélène ; De Masson, Adèle</creator><creatorcontrib>Ta, Van Anh ; Battistella, Maxime ; Zhao, Lin Pierre ; Dobos, Gabor ; Ram-Wolff, Caroline ; Madelaine, Isabelle ; Bories, Jean-Christophe ; Tournilhac, Olivier ; Rouanet, Jacques ; Veyrat-Masson, Richard ; Bouaziz, Jean-David ; Marie-Cardine, Anne ; Bagot, Martine ; Bensussan, Armand ; Moins-Teisserenc, Hélène ; De Masson, Adèle</creatorcontrib><identifier>ISSN: 0022-202X</identifier><identifier>EISSN: 1523-1747</identifier><identifier>DOI: 10.1016/j.jid.2023.01.009</identifier><identifier>PMID: 36716922</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Bioengineering ; Cancer ; Dermatology ; Human health and pathology ; Humans ; Life Sciences ; Lymphoma, B-Cell ; Lymphoma, T-Cell, Cutaneous - drug therapy ; Lymphoma, T-Cell, Cutaneous - pathology ; Nuclear medicine ; Skin Neoplasms - drug therapy ; Skin Neoplasms - genetics ; Skin Neoplasms - pathology</subject><ispartof>Journal of investigative dermatology, 2023-07, Vol.143 (7), p.1329-1332.e3</ispartof><rights>2023 The Authors</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3381-4b1aa21be74d597d4c9a8039cabb08c6472b7b66410086a2bd98770253d421383</citedby><cites>FETCH-LOGICAL-c3381-4b1aa21be74d597d4c9a8039cabb08c6472b7b66410086a2bd98770253d421383</cites><orcidid>0000-0002-2544-7197 ; 0000-0001-5035-4470 ; 0000-0001-7828-6211 ; 0000-0003-1602-7534 ; 0000-0002-9438-621X ; 0000-0002-7053-7431 ; 0000-0002-6129-655X ; 0000-0002-4993-2461 ; 0000-0002-0409-2497 ; 0000-0001-9924-6446 ; 0000-0002-6128-9536 ; 0000-0002-6593-2453 ; 0000-0002-5821-0786 ; 0000-0002-1631-5192 ; 0000-0002-7353-0585 ; 0000-0001-7793-3317 ; 0000-0002-0400-1954</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36716922$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04613153$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Ta, Van Anh</creatorcontrib><creatorcontrib>Battistella, Maxime</creatorcontrib><creatorcontrib>Zhao, Lin Pierre</creatorcontrib><creatorcontrib>Dobos, Gabor</creatorcontrib><creatorcontrib>Ram-Wolff, Caroline</creatorcontrib><creatorcontrib>Madelaine, Isabelle</creatorcontrib><creatorcontrib>Bories, Jean-Christophe</creatorcontrib><creatorcontrib>Tournilhac, Olivier</creatorcontrib><creatorcontrib>Rouanet, Jacques</creatorcontrib><creatorcontrib>Veyrat-Masson, Richard</creatorcontrib><creatorcontrib>Bouaziz, Jean-David</creatorcontrib><creatorcontrib>Marie-Cardine, Anne</creatorcontrib><creatorcontrib>Bagot, Martine</creatorcontrib><creatorcontrib>Bensussan, Armand</creatorcontrib><creatorcontrib>Moins-Teisserenc, Hélène</creatorcontrib><creatorcontrib>De Masson, Adèle</creatorcontrib><title>CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas</title><title>Journal of investigative dermatology</title><addtitle>J Invest Dermatol</addtitle><subject>Bioengineering</subject><subject>Cancer</subject><subject>Dermatology</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Lymphoma, B-Cell</subject><subject>Lymphoma, T-Cell, Cutaneous - drug therapy</subject><subject>Lymphoma, T-Cell, Cutaneous - pathology</subject><subject>Nuclear medicine</subject><subject>Skin Neoplasms - drug therapy</subject><subject>Skin Neoplasms - genetics</subject><subject>Skin Neoplasms - pathology</subject><issn>0022-202X</issn><issn>1523-1747</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMGO0zAQhi0EYsvCA3BBOYK0CTO2YyfiVIWFXakICRWJm-U4066rJil2Wqlvj6sse9yTpfH3_5r5GHuPUCCg-rwrdr4rOHBRABYA9Qu2wJKLHLXUL9kCgPM8ff-5Ym9i3EHKyLJ6za6E0qhqzhfsR_NVVNnahi1NfthmfsiW222gGP2JbrJ1IDv1NEz5L9oE66YxnLPmONmBxmPM1nlD-322OveHh7G38S17tbH7SO8e32v2-9vturnLVz-_3zfLVe6EqDCXLVrLsSUtu7LWnXS1rUDUzrYtVE5JzVvdKiURoFKWt11daQ28FJ3kKCpxzT7NvQ92bw7B9zaczWi9uVuuzGUGUqHAUpwwsR9n9hDGv0eKk-l9dGnt-QbDtUYhZKlkQnFGXRhjDLR56kYwF-NmZ5JxczFuAE0ynjIfHuuPbU_dU-K_4gR8mQFKQk6egonO0-Co84HcZLrRP1P_D_Pgjeg</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>Ta, Van Anh</creator><creator>Battistella, Maxime</creator><creator>Zhao, Lin Pierre</creator><creator>Dobos, Gabor</creator><creator>Ram-Wolff, Caroline</creator><creator>Madelaine, Isabelle</creator><creator>Bories, Jean-Christophe</creator><creator>Tournilhac, Olivier</creator><creator>Rouanet, Jacques</creator><creator>Veyrat-Masson, Richard</creator><creator>Bouaziz, Jean-David</creator><creator>Marie-Cardine, Anne</creator><creator>Bagot, Martine</creator><creator>Bensussan, Armand</creator><creator>Moins-Teisserenc, Hélène</creator><creator>De Masson, Adèle</creator><general>Elsevier Inc</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-2544-7197</orcidid><orcidid>https://orcid.org/0000-0001-5035-4470</orcidid><orcidid>https://orcid.org/0000-0001-7828-6211</orcidid><orcidid>https://orcid.org/0000-0003-1602-7534</orcidid><orcidid>https://orcid.org/0000-0002-9438-621X</orcidid><orcidid>https://orcid.org/0000-0002-7053-7431</orcidid><orcidid>https://orcid.org/0000-0002-6129-655X</orcidid><orcidid>https://orcid.org/0000-0002-4993-2461</orcidid><orcidid>https://orcid.org/0000-0002-0409-2497</orcidid><orcidid>https://orcid.org/0000-0001-9924-6446</orcidid><orcidid>https://orcid.org/0000-0002-6128-9536</orcidid><orcidid>https://orcid.org/0000-0002-6593-2453</orcidid><orcidid>https://orcid.org/0000-0002-5821-0786</orcidid><orcidid>https://orcid.org/0000-0002-1631-5192</orcidid><orcidid>https://orcid.org/0000-0002-7353-0585</orcidid><orcidid>https://orcid.org/0000-0001-7793-3317</orcidid><orcidid>https://orcid.org/0000-0002-0400-1954</orcidid></search><sort><creationdate>202307</creationdate><title>CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas</title><author>Ta, Van Anh ; Battistella, Maxime ; Zhao, Lin Pierre ; Dobos, Gabor ; Ram-Wolff, Caroline ; Madelaine, Isabelle ; Bories, Jean-Christophe ; Tournilhac, Olivier ; Rouanet, Jacques ; Veyrat-Masson, Richard ; Bouaziz, Jean-David ; Marie-Cardine, Anne ; Bagot, Martine ; Bensussan, Armand ; Moins-Teisserenc, Hélène ; De Masson, Adèle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3381-4b1aa21be74d597d4c9a8039cabb08c6472b7b66410086a2bd98770253d421383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Bioengineering</topic><topic>Cancer</topic><topic>Dermatology</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Lymphoma, B-Cell</topic><topic>Lymphoma, T-Cell, Cutaneous - drug therapy</topic><topic>Lymphoma, T-Cell, Cutaneous - pathology</topic><topic>Nuclear medicine</topic><topic>Skin Neoplasms - drug therapy</topic><topic>Skin Neoplasms - genetics</topic><topic>Skin Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ta, Van Anh</creatorcontrib><creatorcontrib>Battistella, Maxime</creatorcontrib><creatorcontrib>Zhao, Lin Pierre</creatorcontrib><creatorcontrib>Dobos, Gabor</creatorcontrib><creatorcontrib>Ram-Wolff, Caroline</creatorcontrib><creatorcontrib>Madelaine, Isabelle</creatorcontrib><creatorcontrib>Bories, Jean-Christophe</creatorcontrib><creatorcontrib>Tournilhac, Olivier</creatorcontrib><creatorcontrib>Rouanet, Jacques</creatorcontrib><creatorcontrib>Veyrat-Masson, Richard</creatorcontrib><creatorcontrib>Bouaziz, Jean-David</creatorcontrib><creatorcontrib>Marie-Cardine, Anne</creatorcontrib><creatorcontrib>Bagot, Martine</creatorcontrib><creatorcontrib>Bensussan, Armand</creatorcontrib><creatorcontrib>Moins-Teisserenc, Hélène</creatorcontrib><creatorcontrib>De Masson, Adèle</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of investigative dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ta, Van Anh</au><au>Battistella, Maxime</au><au>Zhao, Lin Pierre</au><au>Dobos, Gabor</au><au>Ram-Wolff, Caroline</au><au>Madelaine, Isabelle</au><au>Bories, Jean-Christophe</au><au>Tournilhac, Olivier</au><au>Rouanet, Jacques</au><au>Veyrat-Masson, Richard</au><au>Bouaziz, Jean-David</au><au>Marie-Cardine, Anne</au><au>Bagot, Martine</au><au>Bensussan, Armand</au><au>Moins-Teisserenc, Hélène</au><au>De Masson, Adèle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas</atitle><jtitle>Journal of investigative dermatology</jtitle><addtitle>J Invest Dermatol</addtitle><date>2023-07</date><risdate>2023</risdate><volume>143</volume><issue>7</issue><spage>1329</spage><epage>1332.e3</epage><pages>1329-1332.e3</pages><issn>0022-202X</issn><eissn>1523-1747</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36716922</pmid><doi>10.1016/j.jid.2023.01.009</doi><orcidid>https://orcid.org/0000-0002-2544-7197</orcidid><orcidid>https://orcid.org/0000-0001-5035-4470</orcidid><orcidid>https://orcid.org/0000-0001-7828-6211</orcidid><orcidid>https://orcid.org/0000-0003-1602-7534</orcidid><orcidid>https://orcid.org/0000-0002-9438-621X</orcidid><orcidid>https://orcid.org/0000-0002-7053-7431</orcidid><orcidid>https://orcid.org/0000-0002-6129-655X</orcidid><orcidid>https://orcid.org/0000-0002-4993-2461</orcidid><orcidid>https://orcid.org/0000-0002-0409-2497</orcidid><orcidid>https://orcid.org/0000-0001-9924-6446</orcidid><orcidid>https://orcid.org/0000-0002-6128-9536</orcidid><orcidid>https://orcid.org/0000-0002-6593-2453</orcidid><orcidid>https://orcid.org/0000-0002-5821-0786</orcidid><orcidid>https://orcid.org/0000-0002-1631-5192</orcidid><orcidid>https://orcid.org/0000-0002-7353-0585</orcidid><orcidid>https://orcid.org/0000-0001-7793-3317</orcidid><orcidid>https://orcid.org/0000-0002-0400-1954</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-202X |
| ispartof | Journal of investigative dermatology, 2023-07, Vol.143 (7), p.1329-1332.e3 |
| issn | 0022-202X 1523-1747 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_04613153v1 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Bioengineering Cancer Dermatology Human health and pathology Humans Life Sciences Lymphoma, B-Cell Lymphoma, T-Cell, Cutaneous - drug therapy Lymphoma, T-Cell, Cutaneous - pathology Nuclear medicine Skin Neoplasms - drug therapy Skin Neoplasms - genetics Skin Neoplasms - pathology |
| title | CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T17%3A41%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CD38%20Targeting%20in%20Aggressive,%20Treatment-Refractory%20Cutaneous%20T-Cell%20Lymphomas&rft.jtitle=Journal%20of%20investigative%20dermatology&rft.au=Ta,%20Van%20Anh&rft.date=2023-07&rft.volume=143&rft.issue=7&rft.spage=1329&rft.epage=1332.e3&rft.pages=1329-1332.e3&rft.issn=0022-202X&rft.eissn=1523-1747&rft_id=info:doi/10.1016/j.jid.2023.01.009&rft_dat=%3Cproquest_hal_p%3E2771334564%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2771334564&rft_id=info:pmid/36716922&rft_els_id=S0022202X23000271&rfr_iscdi=true |